Delayed puberty in obese boys: comparison with constitutional delayed puberty and response to testosterone therapy.
OBJECTIVE
To evaluate the results of a brief course of testosterone therapy in boys with delayed puberty and to compare the responses seen in boys with constitutional delayed puberty (CDP), boys with obesity, and boys with possible gonadotropin deficiency.


METHODS
A retrospective chart review was done for 36 boys aged 14 years or older, seen between 1983 and 1996 because of delayed puberty, who were given 4 monthly injections of testosterone, 100 mg/mo, and had adequate follow-up.


RESULTS
There were 23 boys whose findings before and after treatment were consistent with a diagnosis of CDP. Testosterone treatment increased the growth rate from 4.3 cm/y to 11.2 cm/y (P <.00001), and mean testis length increased 0.6 to 0.8 cm in all (from a mean of 2.9 to 3.6 cm, P <.00001) in the 4 months after testosterone treatment. Serum testosterone 4 months after therapy was higher than that before therapy (P =.00003). Of 5 boys with growth hormone deficiency but unknown gonadotropin status, 2 had lack of progression after testosterone therapy and were believed to have permanent gonadotropin deficiency. Seven of the 36 boys were obese (body mass index, >25), and 6 had a response to testosterone similar to boys with CDP with clear pubertal progression. One obese boy and one nonobese boy were diagnosed as having isolated gonadotropin deficiency.


CONCLUSIONS
Monitoring the growth and genital responses to a 4-month course of testosterone injections helps to differentiate CDP from gonadotropin deficiency in boys with delayed puberty. Obese boys constitute a distinct category of boys with pubertal delay in terms of their growth, but their response to testosterone is similar to that observed in boys with classic CDP.
Kaplowitz
P
P
Department of Pediatrics, the Medical College of Virginia of Virginia Commonwealth University, Richmond, USA.
D000293:Adolescent; D006062:Gonadotropins / Q000172:deficiency; D006801:Humans; D008297:Male; D009765:Obesity / Q000150:complications / Q000503:physiopathology; D011628:Puberty, Delayed / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D013739:Testosterone / Q000627:therapeutic use*
D006062:Gonadotropins; D013739:Testosterone